{"id":"https://genegraph.clinicalgenome.org/r/7fedb1f5-b08b-4e23-a355-96f9bd6d845ev1.0","type":"EvidenceStrengthAssertion","dc:description":"Autosomal Dominant Epilepsy with Auditory Features (ADEAF), also known as familial temporal lobe epilepsy, is characterized by seizures originating in the temporal lobe associated with auditory symptoms (ringing, buzzing, and distortion of sounds) and receptive aphasia.  The condition can also be associated with non-auditory seizures, including tonic-clonic seizures.  Onset can occur from early childhood through the 5th decade, typically during adolescence or early adulthood, and seizures tend to be well-controlled.  ADEAF is inherited in an autosomal dominant pattern with incomplete penetrance, estimated at approximately 60%.  Rare de novo mutations have been reported and ADEAF is associated with intrafamilial variability.  LGI1 is the primary gene implicated in ADEAF and was initially described in 2002 (Kalichov et al, PMID 11810107). Since that time, numerous families have been reported in the literature, with over 40 disease-causing mutations reported, typically unique to individual families.  The mutation spectrum includes nonsense, frameshift, splice site, missense and large deletions with loss of function as the mechanism of disease (Kalichov et al, PMID 11810107;  Morante-Redolat et al, PMID 11978770;  Chabrol et al, PMID 17296837; Sadleir et al, PMID: 24206907;  Hedera et al, PubMed 15009222;  Michelucci et al, PMID 14510822;  Fanciulli et al, PMID 22496201;  Kesim et al, PMID 26773249).  Supporting experimental evidence includes functional alteration in non-patient cells (Yokoi et al, PMID 25485908),  expression (Fukata et al, PMID 16990550;  Fukata et al, 20133599),  non-human model organism (Yu et al, 20130004;  Baulac et al, 22589250;  Teng et al, 20819949;  Chabrol et al, 20659958;  Fukata et al, 20133599), and rescue in non-human model organism (Fukata et al, 20133599).   A genetic evidence score of 12 and experimental evidence score of 6 results in a total score of 18.  Evidence supporting an association between LGI1 and ADEAF has been replicated over time; therefore, the gene-disease validity has been classified as DEFINITIVE.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/7fedb1f5-b08b-4e23-a355-96f9bd6d845e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-07-07T18:39:07.849Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-09-16T19:23:21.600Z","role":"Publisher"},{"agent":"https://genegraph.clinicalgenome.org/agent/10005","role":"SecondaryContributor"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25ec319f-bfa1-4359-8c48-2a21d1ce723a_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a01b3b9-defa-4f01-8206-22428b02f640","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26773249","rdfs:label":"E5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":12,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/25ec319f-bfa1-4359-8c48-2a21d1ce723a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26773249","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b10b75-05e6-4fea-b5b8-6ef0aff17cb0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.1013T>C (p.Phe338Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351639"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4927a73c-f662-48f7-9186-6f6e18ac5266_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbd2c068-2c99-4a34-8bbf-e2321b66e0ef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22496201","rdfs:label":"III-1","ageType":"AgeAtReport","ageUnit":"https://genegraph.clinicalgenome.org/r/","ageValue":42,"detectionMethod":"SNP array","firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Monthly episodes of high-pitched sounds and unformed voices, usually accompanied by feeling of confusion, from age 15 years.  Tonic clonic seizures.","previousTesting":true,"previousTestingDescription":"Microsatellite analysis previously gave max LOD score of 0.79, routine sequencing was negative.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4927a73c-f662-48f7-9186-6f6e18ac5266_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22496201","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f73af01-66c4-4cb0-a016-79220aae399b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000010.11:g.(93704377_?)_(?_93785620)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/208479"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2218b9a9-165f-4ca3-b391-39fc21b7db2e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9ee7bbd-af4e-4883-9d72-32e548422130","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24206907","rdfs:label":"IV-1 Family B","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequencing of all LGI1 exons","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"ADEAF-auditory aura","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2218b9a9-165f-4ca3-b391-39fc21b7db2e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24206907","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3ab26e0-d33e-4987-a3c0-ddb08e991882","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.673G>T (p.Glu225Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377623825"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/179f6211-9535-450e-9c80-e6f4a82bb24f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Experimental data to support pathogenicity","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97f95433-a667-495f-9b29-8d009540f825","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17296837","rdfs:label":"1-2 Family A","ageType":"AgeAtOnset","ageUnit":"https://genegraph.clinicalgenome.org/r/","ageValue":11,"detectionMethod":"Sequencing of all LGI1 exons","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Partial seizures, bilateral buzzing sounds with speech comprehension impairment.","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/179f6211-9535-450e-9c80-e6f4a82bb24f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17296837","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e08e49b-737b-4814-bd13-0dc238746980","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.431+1G>A (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377621170"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fc18004d-6599-4cd5-80db-bf5b5548fb8c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c18a7668-faaf-492c-bf95-f862944f5d6e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11810107","rdfs:label":"Family A","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":true,"previousTestingDescription":"Linkage and candidate gene sequencing of all genes in region","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/fc18004d-6599-4cd5-80db-bf5b5548fb8c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11810107","allele":{"id":"https://genegraph.clinicalgenome.org/r/60a960c6-a1c8-48eb-8578-a3a663935aa8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.611del (p.Pro204GlnfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA923726066"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3c5db789-c7b0-4f73-af2a-1c568d3aac73_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62fa49c9-6bb6-4b1d-82eb-263894b901cb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15009222","rdfs:label":"III-4 Family A","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequencing of all LGI1 exons; 100 controls","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Partial epilepsy with prominent auditory features and a family history of epilepsy","previousTesting":true,"previousTestingDescription":"Linkage to the locus on chromosome 10q24 that was previously identified in ADLTE by using microsatellite markers D10S200, D10S510, and D10S571","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c5db789-c7b0-4f73-af2a-1c568d3aac73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15009222","allele":{"id":"https://genegraph.clinicalgenome.org/r/330d2475-fee0-4bae-a32a-c849cb936e23","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.329del (p.Ala110ValfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA923726070"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a28aa475-87b5-4108-be9f-a19d5208fe9c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bab3036-a6e0-460d-981f-8bf62b2d68ce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20659151","rdfs:label":"II-2 Family J","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":14,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a28aa475-87b5-4108-be9f-a19d5208fe9c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20659151","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e991d17-3992-459a-8c36-f6f55cafb738","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.598del (p.Cys200AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA923726325"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e4bd4fed-91eb-45ae-b41c-1c0ef55a6bea_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23a01061-29a3-4712-a08e-13ea8c9eabfd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11978770","rdfs:label":"III-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"detectionMethod":"All exons","firstTestingMethod":"Sanger sequencing","previousTesting":true,"previousTestingDescription":"Follow up to a linkage study to refine region of interest.  Positional cloning and candidate gene analysis in genes expressed in brain and CNS.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4bd4fed-91eb-45ae-b41c-1c0ef55a6bea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11978770","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a2f0c73-0f64-4933-be1b-18d6cbb81b28","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.758del (p.Ala253fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347447"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1a0a9de-7a48-4919-8ae3-0226ed43a3e5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Sirerol Piquer et al 2006 PMID 17067999 functional study in HEK293T cells transfected with C200R mutant, demonstrated impaired secretion of LGI1","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/245ad570-fec8-498b-9aea-58b39588e1a0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14510822","rdfs:label":"II-2 Fam I-1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Linkage and LGI1 sequencing of all exons","firstTestingMethod":"Sanger sequencing","previousTesting":true,"previousTestingDescription":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b1a0a9de-7a48-4919-8ae3-0226ed43a3e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14510822","allele":{"id":"https://genegraph.clinicalgenome.org/r/09a167be-5220-4013-a321-3607e0a89723","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.598T>C (p.Cys200Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377623513"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f162ac4a-bd9c-476f-922e-2785dd627355_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/033e19e7-ed98-4a09-9a43-429c4e8b4065","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11810107","rdfs:label":"Family B","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0007359","previousTesting":true,"previousTestingDescription":"Linkage and candidate gene sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f162ac4a-bd9c-476f-922e-2785dd627355_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11810107","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3cb57f2-1297-460a-896f-10768b62510f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005097.4(LGI1):c.360-3C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5432"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a978a508-af47-45d3-b889-816a80734008_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11978770","rdfs:label":"Family ADLTE01","family":{"id":"https://genegraph.clinicalgenome.org/r/a978a508-af47-45d3-b889-816a80734008","type":"Family","rdfs:label":"Family ADLTE01","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":19,"publishedLodScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/02431bc6-ded7-49eb-9cd6-8ba5b1a4230b_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15079011","rdfs:label":"Family G","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/02431bc6-ded7-49eb-9cd6-8ba5b1a4230b","type":"Family","rdfs:label":"Family G","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":4,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c720590-778a-4ab1-a726-aef77bb84502","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6344f777-402d-47f2-bacb-796641a380f2","type":"Finding","dc:description":"Created KO mice with deletion exons 6-7 and confirmed by Western blot.  Homozygous KO mice developed frequent spontaneous seizures, some with tonic clonic seizures.  Heterozygotes did not show spontaneous seizure activity but did mimic ADLTE.   At age postnatal day 28, auditory stimulation induced seizures in a significantly higher percentage of LGI1+/− than wild-type littermates (52% versus 18%, P < 0.03) (Fig. 6A). Typically, audiogenic seizures began suddenly at 5–20 s after the onset of the tone, with wild running, followed by a tonic phase and sudden death in 23% of mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20659958","rdfs:label":"Knock out Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2f790ed1-8e25-4706-8045-86e1d1084fa2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ceeb3b4f-800f-41e9-9771-8065ae64fd43","type":"Finding","dc:description":"All LGI1−/− mice showed spontaneous recurrent generalized seizures after P14, with a sudden onset of wild running and jumping, followed by limb clonus and tonic limb\nextension.  Almost all LGI1−/− mice died suddenly during the postnatal third week (p.3799).  Heterozygotes had no overt abnormalities.  Authors investigated if heterozygotes had lower threshold for seizure induction by PTZ.   Generalized clonic or tonic seizures (seizure score 4 or 5) were observed in 8 LGI1+/− mice (42.1%) compared with only one wild-type mouse (8.3%) (Fig. 1E).   The lethal phenotype in LGI1 -/- mice was rescued by crossbreeding with transgenic mice expressing LGI1 under the neuron specific Thy1 promoter.  Authors found that LGI1 bound to ADAM22 and ADAM23 using tandem affinity purification.  Large scale purification with shotgun proteomic analysis found the global LGI1 complex contained ADAM22, ADAM23, ADAM11, PSD95, PSD93, SAP97, CASK, Lin7 and Kv1.  Targeted disruption of ADAM22, ADAM23 , and Kv1 channel, causes a similar epileptic phenotype (generalized tonic–clonic seizures beginning around the postnatal second or third week) and premature death in mice, suggesting that LGI1, ADAM22, ADAM23, and Kv1 channel are genetically associated and functionally related.  With cell surface binding assay, found LGI1 directly binds to ADAM22 and ADAM23 on cell surface.  Immunohistochemical analysis showed that LGI1 predominantly occurs in the hippocampus and entorhinal cortex. . Specific strong staining was observed in the neuropil of the hippocampus.   Found loss of LGI1 reduces AMPAR mediated synaptic currents based on reduced AMPA/NMDA ratio compared to WT and decreased amplitude of mEPSCs in the presence of tetrodotoxin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20133599","rdfs:label":"Knock out Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/592d812a-8d02-40f9-8f3b-ebb58f1a9351","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca574f1b-8dc1-4078-a077-b276d76f9578","type":"Finding","dc:description":"LGI1 knockout mouse developed myoclonic seizures.  Heterozygous mice did not.   Found increased spontaneous burst discharge frequency compared to WT in the CA region of hippocampi.  Authors found the frequency of miniature excitatory postsynaptic synaptic currents was significantly increased compared to WT indicating increased release of glutamate.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20130004","rdfs:label":"Knock out Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa186fce-8691-4833-9933-9a37a3abd1e9","type":"EvidenceLine","dc:description":"Upgraded given large number of missense variants implicated in human disease that demonstrated secretion abnormality.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0c0fd33-76c1-4c49-ae2b-9d3afc78e832","type":"FunctionalAlteration","dc:description":"Authors demonstrated that 19/22 missense variants were secretion defective using Western blot in HEK293T cells","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25485908","rdfs:label":"Secretion Testing"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/662936d4-11a7-43f3-9daf-4ba1a7c92ffe_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f89dd928-b9a8-46cb-8833-752ad2823aff","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3aa15f8-3b43-4e83-a453-da504a5a616a","type":"Finding","dc:description":"GTEx data","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16787412","rdfs:label":"Immunoblot of human brain tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9a81d21f-54e8-4c93-9b2f-3d1344e2a285","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8542b555-3932-49b9-a917-6e75c18cc7a2","type":"Finding","dc:description":"GTEx","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16990550","rdfs:label":"Immunohistochemistry","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":963,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/JGOmtLl2bkk","type":"GeneValidityProposition","disease":"obo:MONDO_0010898","gene":"hgnc:6572","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_662936d4-11a7-43f3-9daf-4ba1a7c92ffe-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}